Resources

Selected
  • 国电电力 2025年光伏毛利率
Type of publications
Regions
Diseases
273 results found
2025 ∙ Bhattacharya, A. Mark-Uchendu, C. Hansen, C. Evans, J.
Systematic review of mHealth and digital health interventions to improve childhood vaccination uptake in 19 Sub-Saharan African countries
Africa Eastern Mediterranean Benin Burkina Faso Burundi Cameroon Central African Republic Chad Ghana Guinea Kenya Liberia Malawi Mozambique Niger Nigeria Sierra Leone Uganda South Sudan Newborn Children Diphtheria Tetanus Pertussis Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tinessia, A. Sabahelzain, M. M. King, C. Khalatbari-Soltani, S. Gunaratnam, P. Dadari, I. Lorenzo, J. C. Bhaumik, S. Sheel, M.
Systematic review of pro-equity strategies to improve vaccination among priority populations
All age groups Pregnant women Healthcare workers Parents/caregivers Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Yin, Y. Deng, J. Liu, J.
The association between herpes zoster vaccination and the decreased risk of dementia: A systematic review and meta-analysis of cohort studies
Older adults Herpes zoster Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mongan, S. P. Byrnes, J. Kim, H.
The Cost-Effectiveness of the Human Papilloma Virus Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn?-A Systematic Review
Western Pacific Children Adolescents Adults Human papillomavirus (HPV) Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Milne, B. M. Mallett, E. M. Brogly, S. B.
The Effect of COVID-19 Vaccination on Menstrual Cycles of Adolescents and Young Adults: A Systematic Review and Meta-analysis
Adolescents Adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Lei, Z. J. Bai, M. X. Li, M. J. Jin, P. Ding, Y. B.
The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis
Pregnant women COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Yan, X. Liu, Y. Chen, F. Chang, Z. Zhang, Z. Pons-Salort, M. Grassly, N. C.
The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis
Western Pacific China Newborn Children Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Shahrebabak, A. G. Rezaei, M. Shahpar, A. Nezhad, N. Z. Sarasyabi, M. S. Nakhaie, M. Shahrebabak, M. G. Bahri, R. A.
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Clarke, M. McMillan, M. Giles, L. C. Riley, K. Andraweera, P. Richmond, P. C. Mathew, S. M. Marshall, H. S.
The impact of obesity on influenza Vaccine immunogenicity: A systematic review
All age groups Pregnant women Healthcare workers Influenza Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Lee, H. Cho, J. Y. Vietri, J. Dawson, E. Chaiyakunapruk, N.
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations
Adults Older adults Pneumococcal disease Economic aspects Administration
Methodological quality (AMSTAR 2):
Not applicable
Loading...